Todd Wider Sells 74,108 Shares of ASP Isotopes (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPI) Director Todd Wider sold 74,108 shares of the stock in a transaction on Monday, September 15th. The stock was sold at an average price of $8.76, for a total transaction of $649,186.08. Following the completion of the sale, the director directly owned 710,230 shares of the company’s stock, valued at approximately $6,221,614.80. This trade represents a 9.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

ASP Isotopes Stock Up 3.9%

ASPI opened at $9.34 on Friday. The stock has a market cap of $858.44 million, a price-to-earnings ratio of -15.31 and a beta of 3.29. The company has a debt-to-equity ratio of 3.53, a quick ratio of 14.56 and a current ratio of 14.72. The firm’s fifty day moving average is $9.53 and its 200 day moving average is $7.75. ASP Isotopes Inc. has a fifty-two week low of $2.78 and a fifty-two week high of $11.86.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings results on Thursday, August 14th. The company reported ($1.03) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.92). The business had revenue of $1.20 million for the quarter, compared to the consensus estimate of $1.60 million. ASP Isotopes had a negative net margin of 2,181.62% and a negative return on equity of 239.22%. On average, sell-side analysts forecast that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Hedge Funds Weigh In On ASP Isotopes

Several hedge funds have recently added to or reduced their stakes in ASPI. Ameritas Investment Partners Inc. raised its position in ASP Isotopes by 41.2% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock worth $40,000 after purchasing an additional 1,600 shares during the period. The Manufacturers Life Insurance Company grew its stake in shares of ASP Isotopes by 9.9% during the second quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock valued at $153,000 after buying an additional 1,878 shares during the last quarter. Bank of Montreal Can raised its holdings in shares of ASP Isotopes by 8.0% in the second quarter. Bank of Montreal Can now owns 27,000 shares of the company’s stock worth $199,000 after buying an additional 2,000 shares during the period. Rathbones Group PLC lifted its stake in shares of ASP Isotopes by 1.1% during the 2nd quarter. Rathbones Group PLC now owns 208,149 shares of the company’s stock worth $1,532,000 after acquiring an additional 2,220 shares during the last quarter. Finally, BNP Paribas Financial Markets boosted its holdings in ASP Isotopes by 84.9% during the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after acquiring an additional 2,548 shares during the period. 16.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have weighed in on ASPI shares. Canaccord Genuity Group restated a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a research note on Wednesday, September 17th. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Saturday, September 27th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $11.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.